骨质密度测定市场：按细分市场划分的规模、份额、法规、报销、安装基础、预测至 2033 年

骨密度测定使用 X 光来测试和量化患者的骨密度。 骨密度检测用于评估骨折风险、调查身高损失、诊断和监测骨质疏鬆症，以及监测类固醇治疗（或其他可能影响骨密度的药物，例如抗器官排斥药物）的情况。 DXA 设备是骨密度测量的黄金标准。 ADEXA 装置是评估骨质疏鬆症患者髋部和脊椎等脆弱部位骨折风险的重要工具。

虽然价格昂贵，但我们有处理这些零件的设备。 儘管 PDEXA 设备体积小、便宜且便于携带，但它们在手和脚踝等远端解剖部位不太受欢迎，儘管它们更有用。 QUS 设备对于一般患者监测也非常有用，但不太常用。

本报告深入探讨了全球骨密度测定市场，包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响、区域和国家趋势等。

目录

目前市面上的骨密度测量设备及竞争状况

• 对主要产业趋势的见解
• 2015 年至 2033 年骨密度测量设备各细分市场的市场总收入及市场前景
• 有关单位数量、平均售价和市场价值的详细数据

全球、区域与国家见解

• 骨密度测量设备市场的SWOT分析
• 骨密度测试仪市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技的监管状况

Abstract

Bone Densitometers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.

The model discusses in detail the impact of COVID-19 on Bone Densitometers market for the year 2020 and beyond. Bone Densitometers harness X-rays to examine and quantify a patient's bone density. Bone density tests are used to assess fracture risk, investigate height loss, diagnose and monitor osteoporosis, and monitor steroid treatment (or other drugs that may affect bone density such as anti-organ rejection medication). DXA machines are the gold-standard for bone densitometry. ADEXA machines are an important tool for assessing fracture risk in fragile areas of the body in osteoporosis patients, such as the hip and spine.

Although they are more expensive, they are more equipped to handle these areas of the body. PDEXA machines, which are smaller, less expensive and portable are less sought after, though they are far more useful the peripheral anatomies such as hands and ankles. QUS machines are also less commonly used, although they are very useful for monitoring regular patients.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Bone Densitometers and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Bone Densitometers market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Bone Densitometers market.
• Competitive dynamics insights and trends provided for Bone Densitometers market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: GE Healthcare Technologies Inc, Hologic Inc, Diagnostic Medical Systems SA, Swissray Medical AG, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Bone Densitometers marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Bone Densitometers market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Bone Densitometers market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Bone Densitometers market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Bone Densitometers market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable